- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
InSite One couples image streaming with InDex storage
InSite One couples image streaming with InDex storageInSite One has licensed RealTimeImage’s iPACS progressive streaming technology and incorporated it into its own InDex digital image storage and retrieval service, which enables real-time
InSite One couples image streaming with InDex storage
InSite One has licensed RealTimeImages iPACS progressive streaming technology and incorporated it into its own InDex digital image storage and retrieval service, which enables real-time browser-based access to archived lossless DICOM images using LANs, WANs, or dial-up connections. The integration of image streaming capability into InSite Ones InDex service allows clinicians to review and collaborate over any network on diagnostic-quality archived images stored using InDex. The companies debuted their integrated capabilities at the annual meeting of the American Healthcare Radiology Administrators in Nashville earlier this month. RealTimeImage received FDA clearance for iPACS in June 2000.
- Search Again
- Return To HNN Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
